glp-1 treatment clinic phoenix NP Telehealth Weight Loss in Phoenix, AZ: FDA-Approved GLP-1s for Women Decoding GLP-1 Weight Loss Medications

Thats because obesity is a chronic disease, Dr

Phase 1 and Early Development Phase 1 studies in healthy volunteers established proof-of-concept, demonstrating that retatrutide was well-tolerated and produced dose-dependent effects on appetite, food intake, and body weight with acceptable safety profiles

Any significant lifestyle changes should be discussed with a healthcare professional to ensure they align with ongoing treatment

[1] [4] Published phase 2 trial data (Jastreboff et al., NEJM , 2023) reported dose ranges from 1 mg up to 12 mg weekly, with higher doses associated with greater weight loss but also increased rates of gastrointestinal side effects